Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of the NEWS2 + Procalcitonin Association for Early Risk Stratification in Patients Presenting With Infection to the Emergency Department and Its Significance in Oncological Patients

NCT06761118 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.

NCT NCT06761118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06761118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of the NEWS2 + Procalcitonin Association for Early Risk Stratification in Patients Presenting With Infection to the Emergency Department and Its Significance in Oncological Patients
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase
Observational
Overall status
Completed
Start date
February 1, 2023
Completion date
September 30, 2024
Enrollment
1,041 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection